The CPhM dedicated webpage on the new Controlled Substances Regulations can be accessed through the following link:

Controlled Substances Regulations Webpage

August 14, 2026

Friday Five (August 14, 2026)

The August 14, 2026 edition of the Friday Five is now available.

  1. Continuing Competency Matters 
  2. Applications Open for Pharmacist Council Vacancy 
  3. Summer Newsletter Now Available 
  4. Reminder: Online Sales of Schedule 2 and 3 Drugs Are Not Permitted 
  5. Professional Development Opportunities & Upcoming Events

Continuing Competency Matters   

As mentioned in the July 17, 2026 Continuing Competency Matters, the CPhM approved Visionary CCP Framework is now available in the Registrant Portal and via the publicly available Continuing Competency Program Project webpage. 

The public webpage provides the Framework, Principles, Quick Facts, FAQ, Publications, and links for provision of feedback. Pharmacy professionals should refer to this FAQ that provides responses to several questions that were raised during feedback sessions.  

The Continuing Competency Project folder in the Registrant Portal provides: 

  • the approved Visionary CCP Framework and an overview of the changes from the original revisions that were discussed at the webinar and Focus Groups;  
  • the webinar recording and slides; 
  • the Q & A based on the questions raised via the webinar updated to align with the approved Visionary CCP Framework, and; 
  • the running compilation of Continuing Competency Matters from May 2025 – August 2026 in a single document as requested by registrants.   

The summary of feedback received from the focus groups and via the webinar surveys will be added to the Registrant Portal shortly. 

As this information is now available on the CPhM Registrant Portal, information presented in the Continuing Competency Matters will shift to highlighting new information that becomes available on the website, calls for participation in CCP activities, and updates to timeframes and planning. 

Timeframe Update: Pilot Project Knowledge Application Assessment (KAA): As addressed in the last Continuing Competency Matters, registrant feedback emphasized that the pilot project should not occur during the influenza and COVID-19 vaccination period of mid-October to mid-December. To avoid this period, the KAA Pilot Project will be shifted to early 2027.  

Thank you to those pharmacists who have indicated interest in the pilot project on the Knowledge Application Assessment. We will follow up with you directly in the fall to provide updates and determine your continued interest in participating. We are continuing to seek interested pharmacists, so please click on the following link if you wish to participate or are interested in receiving more information: https://forms.office.com/r/3LMpyVAT8d. 

CQI Update: The delay in the KAA Pilot Project provides the potential to field test both the use of patient reported experience measures (PREMs) by community pharmacy teams and the coaching process. Watch for further details on opportunities to participate in these field tests in the fall. 

Applications Open for Pharmacist Council Vacancy 

The College of Pharmacists of Manitoba (CPhM) is seeking applications from pharmacists interested in filling a vacant Council position for the remainder of a three-year term ending in May 2028. 

Applications are currently being accepted. All eligible pharmacists are encouraged to apply and contribute to the governance and strategic direction of CPhM.  The Call for Applications closes September 4, 2026. 

One candidate will be selected to fill the vacancy. CPhM pharmacist registrants are eligible to apply to fill this position if you are:    

  • A full registered pharmacist and meet the eligibility criteria to serve on Council, as outlined in section 6.10 of the bylaws.    
  • Eager to participate in CPhM governance and have competencies, skills, and attributes that contribute to the Council competency matrix .  

CPhM Council oversees the organization’s strategic direction and ensures that CPhM fulfills its mandate of upholding the public interest through effective regulation of pharmacy professionals.  

Interested pharmacists must complete the online application form and submit a resume to info@cphm.ca by 4:00 p.m. on September 4, 2026. Additional information about the Council selection process can be found on the following webpage https://cphm.ca/council-appointments/ . 

Questions and resumes can be sent to info@cphm.ca by 4:00 p.m. on September 4, 2026. 

Summer Newsletter Now Available  

Discover the latest insights and developments with the release of the Summer 2026 Newsletter from the College of Pharmacists of Manitoba (CPhM).     

This edition features a Safety IQ article on a case example highlighting the importance of Continuous Quality Improvement and an overview of all the latest CPhM developments, including professional development opportunities and updates on the ongoing Strategic Plan. Click here to read: https://cphm.ca/feature-story/summer-2026-newsletter/ 

To stay informed on vital pharmacy topics, read the latest issue of the CPhM Newsletter. We value your input and welcome any feedback or inquiries. Please direct your comments to Communications at communications@cphm.ca.  

Reminder: Online Sales of Schedule 2 and 3 Drugs Are Not Permitted 

The National Drug Schedules (NDS) program, administered by the National Association of Pharmacy Regulatory Authorities (NAPRA), provides a national framework that outlines the conditions under which Health Canada-authorized drugs may be sold. 

The NDS consists of three schedules / four categories of drugs (Schedule 1, Schedule 2, Schedule 3 and Unscheduled). In Manitoba, the NDS is adopted through the Pharmaceutical Regulation. 

To support the safe sale of Schedule 2 and Schedule 3 drugs, Council has approved the following practice directions: 

Under these practice directions: 

  • A pharmacist must conduct an assessment before the sale of a Schedule 2 drug. 
  • A pharmacist must be available to assist with patient self-selection and provide professional intervention when necessary for the sale of a Schedule 3 drug. 
  • The online sale of Schedule 2 and Schedule 3 drugs by Manitoba pharmacies is not allowed. This includes sales through a pharmacy’s website or through third-party online platforms and mobile apps. 
  • Pharmacies are encouraged to review their websites, online stores, and any third-party e-commerce platforms to ensure compliance with these requirements. 

To determine whether a drug is classified as Schedule 2 or Schedule 3, consult the National Drug Schedule on the NAPRA website. The NDS can be filtered by drug schedule or searched for a specific drug.  

Professional Development Opportunities & Upcoming Events

Effective Communication in Pharmacy Practice, CPhM Mandatory Professional Development (November 2025 – October 2027) 

Optimizing Prescription Writing: Essentials and Updates in 30 Minutes 

  • Click here to access the prerecorded webinar 
  • 1.0 CEU

Essentials in Advanced Patient Care for Pharmacists Micro-Certificate Program, College of Pharmacy, University of Manitoba  

Interested pharmacists can visit the program website for detailed information and to begin the application process. For further inquiries, please email PharmacyPD@umanitoba.ca.   

Canadian Society of Healthcare-Systems Pharmacy Fundamentals of CAR T-Cell Therapy